Vironova AB Revenue and Competitors

Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better informed decisions to secure robust bioprocessing and final product quality. The Vironova offering comprises: Cost effective, fast electron microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis. Viral clearance testing performed in GLP and BSLIII certified laboratories. MiniTEMâ„¢, a bench-top transmission electron microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics. Founded in 2005 as a result of interdisciplinary research at the Karolinska Institute in Stockholm Sweden, Vironova has quickly established a following of global customers working in highly-regulated and quality-demanding industries such as vaccine development, the pharmaceutical industry and material science.